Ferritin levels and recovery in diabetic ketoacidosis
Part of Hormones & metabolism clinical trials.
This study looks at whether the level of a protein called ferritin in your blood can help predict how well you recover from diabetic ketoacidosis (DKA). If you have DKA and are over 18, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have type 1 or type 2 diabetes and are currently in diabetic ketoacidosis (DKA).
- You do not have iron deficiency anemia or iron overload.
- You do not have an active infection (bacterial, viral, or fungal).
- You do not have other serious health conditions like heart attack, stroke, kidney disease, liver disease, cancer, or are pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children age 1 to 16 who are in the hospital for diabetic ketoacidosis (DKA). It aims to understand how these children are doing and what treatments might work best.
This trial tests if not eating (fasting) during standard treatment for diabetic ketoacidosis can help patients recover faster or better. It compares the usual treatment to the same treatment without food intake.
This trial tests if an IV medicine called arginine hydrochloride can help manage diabetic ketoacidosis (DKA) in people with type 2 diabetes. It's for those who come to the ER with very high blood sugar and ketones.
This trial tests a solution called REAMBERIN to help rehydrate people with diabetic ketoacidosis (DKA). If you are 18–75 and have DKA with very high blood sugar and acidic blood, you may be able to join.
This study looks at signs of acute organ injury in children newly diagnosed with type 1 diabetes. It aims to understand how the body reacts to diabetes and its treatment, which could help improve care for kids like yours.
This study tests a dual continuous ketone and glucose monitor to help prevent diabetic ketoacidosis (DKA) in people with type 1 diabetes who are starting SGLT2 inhibitor treatment. SGLT2 inhibitors are a newer type of diabetes medicine, but they can increase the risk of DKA. The device may make using these medicines safer.
Hear when a new Diabetic Ketoacidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.